James Berg, Interim CEO (Beg 01/20 - End 12/20), Clinical Biotechnology Research Institute at RSFH

Annual compensation details

$576,206

Interim CEO (Beg 01/20 - End 12/20)

2020

$577k related

49 hrs/wk

Total compensation by year

2020

Other employees at Clinical Biotechnology Research Institute at RSFH

Wael Haidar, M.D.

Board Member (Beg 01/20), BSMH Chief Clinical Officer

$2,013,417

$0 from org$1,492,186 from related$521,231 other

Brian White

Board Member (End 03/20); Atlantic Group President - BSMH

$2,006,480

$0 from org$1,968,502 from related$37,978 other

Joseph Gage Jr, Jd

Board Member (Beg 03/20); BSMH Chief HR Officer

$1,519,347

$0 from org$1,252,571 from related$266,776 other

Lorraine Lutton

Former Chief Executive Officer

$1,408,553

$0 from org$1,401,488 from related$7,065 other

Brian Cuddy, M.D.

Chair, Neurosurgeon - Rsfpp

$1,095,307

$0 from org$1,025,169 from related$70,138 other

Bret D Johnson

CFO and Senior Vice President / Treasurer (End 05/20)

$737,362

$0 from org$710,578 from related$26,784 other

Henry West, M.D.

Board Member, Surgeon - Rsfpp

$610,322

$0 from org$555,493 from related$54,829 other

Brian Yanofchick

Board Member (Beg 01/20); Chief Sponsorship Officer Atlantic Grp. - BSMH

$597,740

$0 from org$575,471 from related$22,269 other

John B Holloway Jr

Board Member, CEO - MSSC

$495,001

$0 from org$464,000 from related$31,001 other

James Berg

Annual compensation details

Total compensation by year

Compare the compensation of James Berg to:

Other employees at Clinical Biotechnology Research Institute at RSFH

Other people named James Berg

Revisions to this profile

Get an email update when compensation for James Berg is updated

Related Jobs

Other people named James Berg